CAAS Capital Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-91,296	Closed	-$6.44M	–	877
2020 Q4	$6.44M	Buy	+91,296	New	+$6.44M	0.06%	110